Phibro Animal Health Co. (NASDAQ:PAHC) Position Trimmed by Villanova Investment Management Co LLC

Villanova Investment Management Co LLC trimmed its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 26.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 85,588 shares of the company’s stock after selling 31,210 shares during the quarter. Phibro Animal Health comprises 2.1% of Villanova Investment Management Co LLC’s portfolio, making the stock its 18th largest position. Villanova Investment Management Co LLC owned approximately 0.21% of Phibro Animal Health worth $1,927,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in PAHC. Price T Rowe Associates Inc. MD raised its holdings in shares of Phibro Animal Health by 7.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 15,393 shares of the company’s stock valued at $200,000 after buying an additional 1,063 shares during the last quarter. CWM LLC grew its holdings in shares of Phibro Animal Health by 89.8% in the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after acquiring an additional 1,035 shares during the last quarter. Cardinal Capital Management lifted its stake in Phibro Animal Health by 4.7% during the second quarter. Cardinal Capital Management now owns 56,027 shares of the company’s stock valued at $940,000 after buying an additional 2,520 shares in the last quarter. Summit Securities Group LLC acquired a new position in Phibro Animal Health in the 2nd quarter worth approximately $83,000. Finally, Acadian Asset Management LLC grew its holdings in shares of Phibro Animal Health by 6.3% during the second quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock valued at $12,027,000 after buying an additional 42,299 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors.

Phibro Animal Health Stock Down 3.0 %

PAHC opened at $22.92 on Friday. The firm has a market cap of $928.26 million, a price-to-earnings ratio of 53.30, a PEG ratio of 0.60 and a beta of 0.51. Phibro Animal Health Co. has a twelve month low of $10.03 and a twelve month high of $25.98. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23. The firm’s 50-day simple moving average is $23.42 and its 200-day simple moving average is $20.34.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, November 27th. This represents a $0.48 dividend on an annualized basis and a yield of 2.09%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 111.63%.

Analyst Ratings Changes

PAHC has been the topic of several research analyst reports. JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price target on the stock. Bank of America upped their price target on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Friday, August 30th. StockNews.com upgraded shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research report on Thursday, November 28th. Finally, Barclays upped their target price on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research note on Tuesday, November 12th. Three research analysts have rated the stock with a sell rating, one has given a hold rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $16.50.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.